Is a complete NSE/NATCOPHARM research report available?

No complete published report is available for nse/NATCOPHARM (NSE/NATCOPHARM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

nse/NATCOPHARM stock profile: metrics, valuation and analysis

Market cap	146.6B
Revenue (ttm)	34.8B
Net income (ttm)	11.4B
EPS (ttm)	₹63.9
Shares out	179.1M
P/E (trailing)	12.8x
P/E (forward)	18.8x
Dividend	₹5.00 (0.60%)
Volume	236,465
Beta	0.16

All NSE/NATCOPHARM indicators

Market & fundamental data

Available fields

228

Groups with data

Currency

INR

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	4,199
Employees Change	183%
Employees Change Percent	4.56
Enterprise value	INR 132.5B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	39.64
Industry PE Fwd	33.97
Isin	INE987B01026
Last refreshed	2026-09-11
Market cap	INR 146.6B
Price	INR 819
Price currency	INR
Rev Per Employee	7,860,591.02x
Sector	Healthcare
Sector PE	48.17
Sector PE Fwd	38.6
Sic	2834
Symbol	nse/NATCOPHARM
Website	https://www.natcopharma.co.in

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.8%
EV Earnings	11.58x
EV/EBIT	13.42x
EV/EBITDA	11.03x
EV/FCF	9.6x
EV/Sales	3.8x
FCF yield	9.41%
Forward P/E	18.8x
P/B ratio	1.59x
P/E ratio	12.81x
P/S ratio	4.21x
PE Ratio10 Y	24.96x
PE Ratio3 Y	11.72x
PE Ratio5 Y	22.87x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	24.56%
EBITDA Margin	30.7%
FCF margin	33.81%
Gross margin	82.64%
Gross Profit	INR 28.8B
Gross Profit Growth	-21.18%
Gross Profit Growth Q	-46.37%
Gross Profit Growth3 Y	7.98%
Gross Profit Growth5 Y	14.13%
Net Income	INR 11.4B
Net Income Growth	-32.59%
Net Income Growth Q	-57.04%
Net Income Growth Qo Q	-22.92%
Net Income Growth Years	0%
Net Income Growth3 Y	11.97%
Net Income Growth5 Y	23.82%
Pretax Margin	35.45%
Profit Margin	32.84%
Profit Per Employee	INR 2.6M
Profitable Quarters	INR 17
Profitable Years	22
Roa5y	10.08
Roe5y	18.08
ROIC	10.16
Roic5y	19.38

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	2.92%
Cagr15y	21.54%
Cagr1y	-2.16%
Cagr20y	20.14%
Cagr3y	-1.95%
Cagr5y	-2.85%
Div CAGR10	8.45%
Div CAGR3	-20.63%
Div CAGR5	-5.59%
EPS Growth	-32.59
EPS Growth Q	-57.04
EPS Growth Qo Q	-22.93
EPS Growth Years	0
EPS Growth3 Y	12.59
EPS Growth5 Y	24.29
FCF Growth	6.51%
FCF Growth3 Y	25.22%
FCF Growth5 Y	99.02%
OCF Growth	4.21%
OCF Growth10 Y	31.75%
OCF Growth3 Y	27.7%
OCF Growth5 Y	42.7%
Revenue Growth	-20.73x
Revenue Growth Q	-44.68x
Revenue Growth Qo Q	-1x
Revenue Growth Years	0x
Revenue Growth3 Y	5.55x
Revenue Growth5 Y	12.91x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 21.3B
Debt	INR 7.1B
Debt EBITDA	INR 0.67
Debt Equity	INR 0.08
Debt FCF	INR 0.52
Equity	INR 92.2B
Interest Coverage	18.41
Net Cash	INR 14.2B
Net Cash By Market Cap	INR 9.65
Net Cash Growth	-36.18%
Net Debt EBITDA	INR -1.32
Net Debt Equity	INR -0.15
Net Debt FCF	INR -1.03
Tangible Book Value	INR 89.6B
Tangible Book Value Per Share	INR 501
WACC	5.19

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0%
Dividend Growth	-10%
Dividend Growth Years	0%
Dividend per share	INR 5
Dividend Years	18
Dividend Yield	0.6%
Ex Div Date	2026-08-20
Last Dividend	INR 1.5
Payout Frequency	Semi-Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	33.37%
1Y total return	-2.16%
200-day SMA	945.4
3Y total return	-5.73%
50-day SMA	907.3
50-day SMA vs 200-day SMA	50under200
5Y total return	-13.48%
All Time High	1,639
All Time High Change	-50.04%
All Time High Date	2024-09-12
All Time Low	1.72
All Time Low Change	47,504.65%
All Time Low Date	2001-07-10
ATR	21.79
Beta	0.16
Beta1y	0.25
Beta2y	0.26
Ch YTD	-9.33
High	832.2
High52	1,226.8
High52 Date	2026-05-12
High52ch	-33.26%
Low	816
Low52	789
Low52 Date	2025-09-30
Low52ch	3.78%
Ma50ch	-9.75%
Price vs 200-day SMA	-13.39%
RSI	29.52
RSI Monthly	43.42
RSI Weekly	37.48
Sharpe ratio	-0.03x
Sharpe Ratio3y	0.02x
Sharpe Ratio5y	-0.07x
Sortino ratio	0.11
Sortino Ratio3y	0.18
Sortino Ratio5y	0.07
Total Return	0.61%
Tr YTD	-9.02
Tr15y	1,764.46%
Tr1m	-10.52%
Tr1w	-2.9%
Tr3m	-5.18%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	83,684,216%
Net Borrowing	4,236,000,000
Shares Insiders	29.39%
Shares Institutions	11.15%
Shares Out	179,109,870
Shares Qo Q	0.01%
Shares Yo Y	-0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	477,970.8x
Bv Per Share	514.9
CAPEX	INR -3.9B
Ch10y	22.71
Ch15y	1,558.5
Ch1m	-10.67
Ch1w	-2.9
Ch1y	-2.67
Ch20y	3,187
Ch3m	-5.34
Ch3y	-7.14
Ch5y	-16.47
Ch6m	-18.34
Change	-0.91%
Change From Open	-0.82
Close	826.3
Days Gap	-0.09
Depreciation Amortization	2,137,500,000
Dollar Volume	193,617,542
Earnings Date	2026-08-14
EBIT	INR 8.6B
EBITDA	INR 10.7B
EPS	INR 63.89
F Score	3
FCF	INR 13.8B
FCF EV Yield	10.42x
FCF Per Share	INR 77.05
Financing CF	2,975,000,000
Fiscal Year End	March
Founded	1,981
Graham Number	860.35967
Graham Upside	5.08
Income Tax	INR 907M
Investing CF	-20,817,000,000
Is Primary Listing	1
Last Earnings Date	2026-08-14
Last Report Date	2026-06-30
Last Split Date	2015-11-26
Last Split Type	Forward
Lynch Fair Value	INR 1,522
Lynch Upside	85.9
Ma150	965.5
Ma150ch	-15.2%
Ma20	858.7
Ma20ch	-4.64%
Net CF	789,000,000
Next Earnings Date	2026-11-06
Open	825.6
P FCF Ratio	10.63
P OCF Ratio	8.29
Payment Date	2026-09-13
Position In Range	17.34
Price Date	2026-09-10
Price EBITDA	INR 13.71
Ptbv Ratio	1.64
Relative Volume	0.5x
Revenue	34,846,000,000x
Tax By Revenue	2.6x
Tax Rate	7.34%
Tr20y	3,824.77%
Tr6m	-18.2%
Volume	236,465

NSE/NATCOPHARM (NSE/NATCOPHARM)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/NATCOPHARM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/NATCOPHARM indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NSE/NATCOPHARM

Frequently asked questions